TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic solutions.
New research shows that palliative patients with pancreatic cancer neither live longer nor experience improved quality of ...
The U.S. Food and Drug Administration (FDA) has granted expanded access for the use of an experimental pancreatic cancer drug ...
A man who lost over 80 pounds before nearly losing his life is sharing his story as a cautionary tale for others seeking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results